Profile
Campbell Wilson is currently a Director at Pharmaceutical Licensing Group Ltd. and a Director at Tarsis Technology Ltd. He previously worked as a Director-Executive Business Development at AstraZeneca PLC and as an Independent Non-Executive Director at Frontier IP Group Plc from 2014 to 2023.
Campbell Wilson active positions
| Companies | Position | Start |
|---|---|---|
Pharmaceutical Licensing Group Ltd. | Director/Board Member | - |
Former positions of Campbell Wilson
| Companies | Position | End |
|---|---|---|
| FRONTIER IP GROUP PLC | Director/Board Member | 21/04/2023 |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Director/Board Member | 13/09/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Frontier IP Group Plc
Frontier IP Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the commercialization of intellectual property | Commercial Services |
Pharmaceutical Licensing Group Ltd. | |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Technology Services |
- Stock Market
- Insiders
- Campbell Wilson
















